WATSON 803 (Meclizine 25 mg)

Pill imprint WATSON 803 has been identified as Meclizine hydrochloride 25 mg.

Meclizine is used in the treatment of vertigo; motion sickness; nausea/vomiting and belongs to the drug class anticholinergic antiemetics. There is no proven risk in humans during pregnancy. Meclizine 25 mg is not subject to the Controlled Substances Act.

See also related documents.

Images for WATSON 803 (Meclizine 25 mg)

Meclizine hydrochloride 25 mg WATSON 803  Front
Meclizine hydrochloride 25 mg WATSON 803  Back
Meclizine hydrochloride 25 mg WATSON 803
Meclizine hydrochloride
Imprint:
WATSON 803
Strength:
25 mg
Color:
White & Yellow
Size:
13.00 mm
Shape:
Elliptical / Oval
Availability:
Rx and/or OTC
Drug Class:
Anticholinergic antiemetics
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Watson Pharmaceuticals
National Drug Code (NDC):
00591-0803
Inactive Ingredients:
silicon dioxide colloidal
corn starch
D&C Yellow No. 10 Lake
lactose monohydrate
microcrystalline cellulose
sodium starch glycolate
stearic acid

View Details Print Page

Pill Identifier

Search by Imprint, Shape or Color

Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...

Search by Drug Name

Search by National Drug Codes (NDC)

Learn how medication, diet, and exercise are key to managing Multiple Sclerosis. Click Here

Close
Hide
(web2)